- News & Views
- Published:
Regenerative medicine
Nature Biotechnology
(2023)Cite this article
Subjects
Human glial progenitors transplanted into a chimeric mouse brain replace sick or older human glia, a finding that could one day lead to new treatments for neurological disease.
Neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and Huntington’s mainly affect the behavior of neurons, but in many cases they are accompanied by defects in the functioning of glial cells1. In a study in Nature Biotechnology, Vieira et al. propose an intriguing cell-based strategy for correcting glial pathology2. Using mice with a humanized glial system, the authors show that newly transplanted human glial progenitor cells (GPCs) can outcompete and replace human glial cells affected either by a Huntington’s disease genotype or by aging. Although much future research will be needed, these results raise the tantalizing possibility of glial cell replacement for the treatment of Huntington’s disease, aging and possibly other neurodegenerative diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
£14.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
-
Valori, C. F., Possenti, A., Brambilla, L. & Rossi, D. Cells 10, 2019 (2021).
-
Vieira, R. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01798-5 (2023).
-
Allen, N. J. & Lyons, D. A. Science 362, 181–185 (2018).
-
Osorio, M. J. et al. Glia 71, 524–540 (2023).
-
Han, X. et al. Cell Stem Cell 12, 342–353 (2013).
-
Benraiss, A. et al. Nat. Commun. 7, 11758 (2016).
-
Das, M. M. & Svendsen, C. N. Aging (Albany NY) 36, 1130–1139 (2015).
CAS
Google Scholar -
Das, M. M. et al. Exp. Neurol. 280, 41–49 (2016).
-
Baloh, R. H. et al. Nat. Med. 28, 1813–1822 (2022).
-
Vera, E., Bosco, N. & Studer, L. Cell Rep. 17, 1184–1192 (2016).
-
Sorrells, S. F. et al. Nature 555, 377–381 (2018).
-
Boldrini, M. et al. Cell Stem Cell 22, 589–599.e5 (2018).
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Moser, V.A., Svendsen, C.N. Survival of the fittest glia.
Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-01944-z
-
Published:
-
DOI: https://doi.org/10.1038/s41587-023-01944-z





